Role of Gliclazide MR in T2D
About the event
In the realm of type 2 diabetes management, a singular goal stands out like a guiding star: mastering glycemic control.
Keeping glycated hemoglobin under 7% should be a primary objective in the management of diabetic patients to ensure reduction of diabetes-related complications and improve their lifelong prognosis.
Modern sulfonylureas (especially Gliclazide MR), have proven to do just this and are recommended in international guidelines due to their low adverse effects. Gliclazide MR offers glycemic control and long-term protection with a good tolerability profile and low risk of hypoglycemia. Find out how it does this by watching the full video:
SCAC 09/23 DM 548 SERVIER- For the exclusive use of health professionals
Don't miss our next events!
Subscribe to our newsletter to receive invitations to upcoming events